- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/033 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing at least one abnormal peptide link in which at least an epsilon- or zeta-amino acid is involved
Patent holdings for IPC class C07K 5/033
Total number of patents in this class: 25
10-year publication summary
|
1
|
2
|
1
|
3
|
4
|
2
|
2
|
2
|
1
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2669 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
3 |
| Bristol-myers Squibb Company | 4764 |
1 |
| Advanced Biodesign | 17 |
1 |
| Cornell University | 3444 |
1 |
| Denka Seiken Co., Ltd. | 79 |
1 |
| The Governing Council of The University of Toronto, | 1547 |
1 |
| National University Corporation Kumamoto University | 410 |
1 |
| National University Corporation Okayama University | 438 |
1 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
1 |
| Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co., Ltd. | 37 |
1 |
| Universite de Sherbrooke | 40 |
1 |
| Waseda University | 474 |
1 |
| Bioventures, LLC | 242 |
1 |
| Orum Therapeutics Inc. | 41 |
1 |
| Encycle Therapeutics | 1 |
1 |
| Immunobiochem Corporation | 3 |
1 |
| Shanghai Huilian Bio-Pharm Co., Ltd | 6 |
1 |
| Mabsoft Therapeutics (Shanghai) Co., Ltd. | 2 |
1 |
| LeonaBio, Inc. | 29 |
1 |
| Other owners | 1 |